Can paracetamol (acetaminophen) be administered to patients with liver impairment?

- Hayward, Kelly L., Powell, Elizabeth E., Irvine, Katharine M., Martin, JH

Coffee consumption and the progression of nafld: A systematic review

- Sewter, Rebecca, Heaney, Susan, Patterson, Amanda

Effect of aerobic exercise training dose on liver fat and visceral adiposity

- Keating, Shelley E., Hackett, Daniel A., Johnson, Nathan A., Parker, Helen M., O'Connor, Helen T., Gerofi, James A., Sainsbury, Amanda, Baker, Michael K., Chuter, Vivienne H., Caterson, Ian D., George, Jacob

Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science

- Fouad, Yasser, Palmer, Melissa, Landgren, Henrik, Karsdal, Morten A., Blake, Martin, Shapiro, David A., Gruss, Hans-Juergen, Sheikh, Muhammad Y., Attia, Dina, Bollipo, Steven, Smith, Alastair D., Freilich, Bradley, Chen, Minjun, Gish, RG, Schuppan, D, Regev, Arie, Banerjee, Rajarshi, Myers, Rob, Riccio, Robert, Torstenson, Richard, Younes, Ramy, Arora, Puneet S.

Resveratrol does not benefit patients with non-alcoholic fatty liver disease

- Chachay, Veronique S., Macdonald, Graeme A., Coombes, Jeff S., Thomas, Gethin P., Cowin, Gary J., Kirkpatrick, Carl M. J., Prins, Johannes B., Hickman, Ingrid J., Martin, Jennifer H., Whitehead, Jonathan P., O'Moore-Sullivan, Trisha M., Lee, Paul, Franklin, Michael, Klein, Kerenaftali, Taylor, Paul J., Ferguson, Maree